Medical devices, healthcare technology and the business of care
510(k) clearance · K260575

AutoGel Pad (400-046,400-005)

Top-Rank Health Care Co., Ltd. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONK260575

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-30 for K260575, a traditional 510(k) submitted by Top-Rank Health Care Co., Ltd. of Shaoxing, CN, with a receipt date of 02/20/2026. The device is listed as AutoGel Pad (400-046,400-005), classified under 21 CFR 892.1570 as Media, Coupling, Ultrasound, product code MUI, in the Radiology specialty and review panel. SESE means the submission was cleared as substantially equivalent; it is not a PMA approval.

The record shows the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The listed correspondent is Microkn Medical Technology Service (Shanghai) Co., Ltd. The source does not state which predicate device was used, what materials or gel formulation the pad contains, what the two model numbers distinguish, or what testing supported equivalence; those details would sit in the underlying 510(k) summary rather than this database entry. No clinical performance or labeling claims are recorded here.

The page was last updated 11/16/2026. Nothing in the record describes indications, use instructions or comparative performance, so no clinical reading should be drawn from the clearance alone.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 30, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260575
Regulatory pathway
510(k) premarket notification
Product code
MUI
Decision code
SESE
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Media, Coupling, Ultrasound.

Product code
MUI
FDA device class
2

FDA decision timeline

  1. K260575 received

    Application receipt date recorded by FDA.

  2. K260575 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MUI

Product / regulatory recordCompanyPathwayDecision dateSource
Foshan Pingchuang Medical Technology Co., Ltd.510(k) clearanceJun 17, 2026FDA
Edgecare, Inc.510(k) clearanceApr 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Top-Rank Health Care Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shaoxing

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records